LOCATE-NAFLD study 2019-2022

The LOCATE-NAFLD study (LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease) is funded by the Medical Research Future Fund Keeping Australians Out of Hospital initiative (GNT1175567)

It builds on previous work by investigator Professor James O’Beirne and will run from 2019-2022. The LOCATE-NAFLD study is a 1:1 parallel randomised trial to compare two alternative models of care for NAFLD (usual care versus LOCATE-NAFLD).  The study proposes to introduce better and faster assessment and stratification of patients with low-risk NAFLD in the community. As a result, the study aims to significantly reduce referrals for hospital-based appointments, and improve surveillance of high-risk disease, resulting in enhanced management of complications that result in avoidable, high cost admissions.

Study investigators:

  • Prof Adrian Barnett, Queensland University of Technology (QUT)
  • Prof James O’Beirne, Sunshine Coast Hospital and Health Service
  • Dr Ingrid Hickman, Metro South Hospital and Health Service
  • Prof Elizabeth Powell, University of Queensland
  • Assoc/Prof Patricia Valery, QIMR Berghofer Medical Research Institute
  • Dr Sanjeewa Kularatna, QUT
  • Dr David Brain, QUT

The study media release is here.